Lumos Diagnostics Holdings Limited (LDX.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.0580 |
| Open | 0.0580 |
| Bid | 0.0560 x N/A |
| Ask | 0.0580 x N/A |
| Day's range | 0.0560 - 0.0590 |
| 52-week range | 0.0100 - 0.1750 |
| Volume | |
| Avg. volume | 3,097,569 |
| Market cap | 27.434M |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Lumos Diagnostics Holdings Full Year 2023 Earnings: US$0.038 loss per share (vs US$0.30 loss in FY 2022)
Lumos Diagnostics Holdings ( ASX:LDX ) Full Year 2023 Results Key Financial Results Revenue: US$10.5m (down 9.4% from...
PR NewswireLumos Receives US FDA Clearance for FebriDx®
Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clearance from the US Food and Drug Administration (FDA) to market its FebriDx® rapid, point-of-care test in the United States.
© 2024 Yahoo. All rights reserved.